Mesenchymal stem/stromal cells in post-menopausal endometrium

Human Reproduction

Volumn 29, Issue 9, 2014, Pages 1895-1905

  Ulrich, D ^a,b,c   Tan, K S ^a   Deane, J ^a   Schwab, K ^a   Cheong, A ^a   Rosamilia, A ^a,b   Gargett, C E ^a,b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

endometrium; mesenchymal stem cells; mesenchymal stromal cells; post menopausal; W5C5

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; BETA1 INTEGRIN; CD146 ANTIGEN; CD34 ANTIGEN; ENDOGLIN; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; HERMES ANTIGEN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ADIPOCYTE; ADIPOGENESIS; ADULT; ARTICLE; BASEMENT MEMBRANE; BODY MASS; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL REGENERATION; CELL RENEWAL; CELL SURFACE; CELL SUSPENSION; CHONDROGENESIS; CLINICAL ARTICLE; CLONING; CLONOGENESIS; CONTROLLED STUDY; CULTURE MEDIUM; ENDOMETRIAL THICKNESS; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM CELL; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; IMAGE ANALYSIS; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIMIT OF QUANTITATION; MENSTRUAL CYCLE; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MESODERM; MIDDLE AGED; MUSCLE DEVELOPMENT; OSTEOBLAST; PHASE 4 CLINICAL TRIAL; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SINGLE CELL ANALYSIS; SMOOTH MUSCLE FIBER; VASCULARIZATION; AGED; CELL CULTURE; CELL LINEAGE; CYTOLOGY; STROMA CELL;

ADULT; AGED; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; ENDOMETRIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; POSTMENOPAUSE; STROMAL CELLS;

EID: 84906078464     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu159     Document Type: Article

References (41)

1. Abberton KM, Healy DL, Rogers PAW. Smooth muscle alpha actin and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles. Hum Reprod 1999; 14:3095-3100.
2. Beltrami AR, Cesselli D, Bergamin N, Marcon P, Rigo S, Puppato E, D'Aurizio F, Verardo R, Piazza S, Pignatelli A et al. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 2007;110:3438-3446. (Pubitemid 350106340)
3. Boennelycke M, Gras S, Lose G. Tissue engineering as a potential alternative or adjunct to surgical reconstruction in treating pelvic organ prolapse. Int Urogynecol J 2013;24:741-747.
4. Buhring HJ, Battula VL, Treml S, Schewe B, Kanz L, VogelW. Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 2007; 1106:262-271. (Pubitemid 47443036)
5. Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, Shull BL, Smith AR. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996; 175:10-17. (Pubitemid 26282199)
6. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007;213:341-347. (Pubitemid 47509711)
7. Cervello I, Mas A, Gil-Sanchis C, Peris L, Faus A, Saunders PTK, Critchley HOD, Simon C. Reconstruction of endometrium from human endometrial side population cell lines. PLoS One 2011;6.
8. Chan RW, Schwab KE, Gargett CE. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod 2004;70:1738-1750. (Pubitemid 38715630)
9. Chan RWS, Kaitu'u-Lino T, Gargett CE. Role of label-retaining cells in estrogen-induced endometrial regeneration. Reprod Sci 2012; 19:102-114.
10. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3:301-313.
11. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006;119(Pt 11):2204-2213. (Pubitemid 43960310)
12. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317. (Pubitemid 44269669)
13. Ettinger B, Bainton L, Upmalis DH, Citron JT, VanGessel A. Comparison of endometrial growth produced by unopposed conjugated estrogens or by micronized estradiol in postmenopausal women. Am J Obstet Gynecol 1997;176:112-117. (Pubitemid 127780758)
14. Furness S, Roberts H, Marjoribanks J, Lethaby A. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev 2012.
15. Gargett CE. Uterine stem cells: what is the evidence? Hum Reprod Update 2007;13:87-101. (Pubitemid 44932827)
16. Gargett CE, Schwab KE, Zillwood RM, Nguyen HP, Wu D. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod 2009;80:1136-1145.
17. Gargett CE, Nguyen HPT, Ye L. Endometrial regeneration and endometrial stem/progenitor cells. Rev Endocr Metab Disord 2012;13:235-251.
18. Gomes AMN, Baracat EC, Simoes MJ, Haidar MA, Focchi GRA, EvencioNeto J, deLima GR. Morphologic and morphometric aspects of the endometrium of postmenopausal women before and after cyclic oestrogen replacement treatment. Eur J Obstet Gynecol Reprod Biol 1997; 74:79-82. (Pubitemid 27272188)
19. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003; 116(Pt 9):1827-1835. (Pubitemid 36582169)
20. Haynesworth SF, Goldberg VM, Caplan AI. Diminution of the number of mesenchymal stem-cells as a cause for skeletal aging. In: Buckwalter JA, Goldberg VM, Woo SLY (eds). Musculoskeletal Soft-Tissue Aging: Impact on Mobility. 1994, 79-87.
21. Hickey M, Lau TM, Russell P, Fraser IS, Rogers PAW. Microvascular density in conditions of endometrial atrophy. Hum Reprod 1996; 11:2009-2013. (Pubitemid 26381454)
22. Hunskaar S, Burgio K, Clark A, Lapitan MC, Nelson R, Sillen U, Thom D. Epidemiology of urinary (UI) and faecal (FI) incontinence and pelvic organ prolapse (POP). 2005. http://www.icsoffice.org/Publications/ICI-3/v1.pdf/chap5. pdf.
23. Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 2012;12:383-396.
24. Masuda H, Anwar SS, Buehring HJ, Rao JR, Gargett CE. A novel marker of human endometrial mesenchymal stem-like cells. Cell Transplant 2012; 21:2201-2214.
25. Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E, Suzuki S, Miyauchi-Hara C, Nagoshi N, Sunabori T et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 2009;206:2483-2496.
26. NguyenHP, Sprung CN, Gargett CE. Differential expression of Wntsignaling molecules between pre- and postmenopausal endometrial epithelial cells suggests a population of putative epithelial stem/progenitor cells reside in the basalis layer. Endocrinology 2012;153:2870-2883.
27. Paulson RJ, Boostanfar R, Saadat P, Mor E, Tourgeman DE, Slater CC, Francis MM, Jain JK. Pregnancy in the sixth decade of life - obstetric outcomes in women of advanced reproductive age. JAMA 2002; 288:2320-2323. (Pubitemid 35291763)
28. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147. (Pubitemid 29282067)
29. Prockop DJ. Marrow stromal cells as steam cells for nonhematopoietic tissues. Science 1997;276:71-74. (Pubitemid 27161245)
30. Rajaraman G, White J, Tan KS, Ulrich D, Rosamilia A, Werkmeister JA, Gargett CE. Optimisation and scale up culture of human endometrial multipotent mesenchymal stromal cells: potential for clinical application. Tissue Eng Part C Methods 2013;19:80-92.
31. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010;28:585-596.
32. Schuring AN, Schulte N, Kelsch R, Roepke A, Kiesel L, Gotte M. Characterization of endometrial mesenchymal stem-like cells obtained by endometrialbiopsyduring routinediagnostics. Fertil Steril 2011a;95:423-426.
33. Schuring AN, Braun J, Wullner S, Kiesel L, Gotte M. mRNA-expression of ERalpha, ERbeta, and PR in clonal stem cell cultures obtained from human endometrial biopsies. ScientificWorldJournal 2011b;11:1762-1769.
34. Schwab KE, Gargett CE. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum Reprod 2007;22:2903-2911. (Pubitemid 351709405)
35. Schwab KE, Chan RWS, Gargett CE. Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle. Fertil Steril 2005;84:1124-1130. (Pubitemid 41396537)
36. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991;78:55-62.
37. Sivasubramaniyan K, Harichandan A, Schumann S, Sobiesiak M, Lengerke C, Maurer A, Kalbacher H, Buhring HJ. Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against sushi domain containing 2. Stem Cells Dev 2013;22:1944-1954.
38. Torrente Y, Polli E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant 2008;17:1103-1113.
39. Ulrich D, Edwards SL, White JF, Supit T, Ramshaw JAM, Lo C, Rosamilia A, Werkmeister JA, Gargett CE. A preclinical evaluation of alternative synthetic biomaterials for fascial defect repair using a rat abdominal hernia model. PLoS One 2012;7:e50044.
40. Ulrich D, Edwards SL, Su K, Tan KS, White JF, RamshawJA, LoC, Rosamilia A, Werkmeister JA, Gargett CE. Human endometrial mesenchymal stem cells modulate the tissue response and mechanical behaviour of polyamide mesh implants for pelvic organ prolapse repair. Tissue Eng 2013a;20:785-798.
41. Ulrich D, Muralitharan R, Gargett C. Toward the use of endometrial and menstrual blood mesenchymal stem cells for cell-based therapies. Expert Opin Biol Ther 2013b;13:1387-1400.